Arranged with the American Society of Microbiology (ASM)

Convenors: Roberto Cauda (Rome, IT), Alan Landay (Chicago, US)

• Introductory remarks of the convenors
  Roberto Cauda (Rome, IT) and Alan Landay (Chicago, US)
• Update on current antiretroviral therapy
  Peter Hunt (San Francisco, US)
• Emergence and transmission of HIV drug resistance: treatment as a preventive tool
  Andrea de Luca (Rome, IT)
• The role of immune activation/inflammation in HIV pathogenesis: implications for therapy
  Michael Lederman (Cleveland, US)
• Cardiovascular risk in HIV: treatment-related or disease-related?
  Jens Lundgren (Copenhagen, DK)

EW02: Challenges and change in pneumonia – focus on Streptococcus pneumoniae and community-acquired MRSA

Arranged with the European Respiratory Society (ERS) for the EU-funded Network of Excellence GRACE (Genomics to Combat Resistance against Antibiotics in Community-acquired LRTI in Europe)

Convenors: Javier Garau (Barcelona, ES) and Roger Finch (Nottingham, UK)

• Impact of conjugate pneumococcal vaccine in North American and European children
  Ron Dagan (Beer Sheva, IL)
• The herd effect of conjugate pneumococcal vaccine on adult LRTI
  Åke Örtqvist (Stockholm, SE)
• Antibiotic choices and controversies in the treatment of pneumococcal lung disease
  Javier Garau (Barcelona, ES)
• CA-MRSA: epidemiology and clinical impact on the lung
  Marc Bonten (Utrecht, NL)
• Current laboratory approaches to the diagnosis of CA-MRSA
  Jan Kluytmans (Breda, NL)
• Management including empirical and definitive antibiotic therapy of MRSA pneumonia
  Robert Masterton (Kilmarnock, UK)

EW03: Pharmacokinetics and pharmacodynamics of anti-infective agents

Arranged with the International Society of Anti-Infective Pharmacology (ISAP)

Convenors: Johan W. Mouton (Nijmegen, NL); Hartmut Derendorf (Gainesville, US)

• Introduction to PK/PD
  Hartmut Derendorf (Gainesville, US)
• PK/PD indices
  Johan W. Mouton (Nijmegen, NL)
• Protein binding/tissue distribution
  Ursula Theuretzbacher (Vienna, AT)
• Use of in vitro models to study emergence of resistance
  Inga Odenholt (Malmö, SE)
• From animal models to the patient
  William A. Craig (Madison, US)

EW04: Recent advances in the management of viral hepatitis

Arranged with the ESCMID Study Group for Viral Hepatitis (ESGVH)

Convenors: Dominique Salmon (Paris, FR); Andy Hoepelman (Amsterdam, NL)

• State-of-the-art of viral diagnosis and resistance
  Valeria Ghisetti (Turin, IT)
• Optimization and future directions in anti-HCV therapy
  Geoffrey M. Dusheiko (London, UK)
• Clinical cases and discussion on guidelines for hepatitis C
  Tarik Asselah (Clichy, FR)
• Clinical cases and discussion on guidelines for hepatitis B
  Andy Hoepelman (Utrecht, NL)
• Clinical cases and discussion on guidelines for HIV and hepatitis coinfection
  Dominique Salmon (Paris, FR)

EW05: Antimicrobial susceptibility testing: current and emerging problems and application of expert rules

Arranged with the European Committee on Antimicrobial Susceptibility Testing (EUCAST)

Convenors: Gunnar Kahlmeter (Vaxjo, SE); Arne C. Rodloff (Leipzig, DE)

• Defining “problems” in antimicrobial susceptibility testing: lessons from external quality assurance
  Derek Brown (Cambridge, UK)
• Staphylococci
  Fred C. Tenover (Sunnyvale, US)
• Streptococci, pneumococci and enterococci
  Roland Leclercq (Caen, FR)
• Gram-negative rods and resistance to beta-lactam drugs
  Christian Giske (Stockholm, SE)
• Gram-negative rods and resistance to non-beta-lactam drugs
  Rafael Cantón (Madrid, ES)
• Anaerobes
  Arne C. Rodloff (Leipzig, DE)

EW06: New and emerging topics in medical mycology

Arranged with the ESCMID Fungal Infection Study Group (EFISG)

Convenors: Malcolm Richardson (Helsinki, FI); Manuel Cuenca-Estrella (Madrid, ES)

• Conventional diagnosis of invasive mycosis. Anything new?
  Cornelia Lass-Flörl (Innsbruck, AT)
• PCR: a useful tool for the diagnosis of aspergillosis
  Peter Donnelly (Nijmegen, NL)
• Challenges in the diagnosis of zygomycosis and emerging pathogens
  Manuel Cuenca-Estrella (Madrid, ES)
• Possible, presumptive, probable, or proven invasive fungal infections – any help?
  Andrew Ullmann (Mainz, DE)
• Chronic respiratory fungal diseases
  David Denning (Manchester, UK)

EW07: Infections in specific populations in the ICU

Arranged with the European Society of Intensive Care Medicine (ESICM)

Convenor: Matthew Falagas (Athens, GR); George Dimopoulos (Athens, GR)

• Rational use of antimicrobials in patients with severe acute pancreatitis
  Jan De Waele (Ghent, BE)
• CA-MRSA infection in the ICU: incidence and management
  Nicola Petrosillo (Rome, IT)
• Antibiotics selection in the elderly ICU patient
  Matthew Falagas (Athens, GR)
• Aspergillosis in the ICU: approach and treatment
  George Dimopoulos (Athens, GR)

EW08: Epidemiology of Clostridium difficile infection

Arranged with the ESCMID Study Group for Clostridium difficile (ESGCD)

Convenor: Petra Gastmeier (Berlin, DE)

• Optimal surveillance methods to study the epidemiology of CDI
  Petra Gastmeier (Berlin, DE)
• Severity of CDI and implications for action
  Anni Virolainen-Julkunen (Helsinki, FI)
• Combating Clostridium difficile ribotype 027 in the UK
  Jean O'Driscoll (Aylesbury, UK)
• Increase of new emerging Clostridium difficile types
  Abraham Goorhuis (Leiden, NL)

EW09: ESBL – how big is the threat?

Arranged with the ESCMID Study Group for Nosocomial Infections (ESGNI)

Convenor: Christian Ruef (Zurich, CH)

• Molecular basis of resistance
  Patrice Nordmann (Paris, FR)
• Epidemiology – incidence, prevalence, modes of transmission
  Hajo Grundmann (Bilthoven, NL)
• Impact on patient outcome
  Evelina Tacconelli (Rome, IT)
• Infection control measures: same as with MRSA, or different?
  Christian Ruef (Zurich, CH)

EW10: Emerging parasites

Arranged with the ESCMID Study Group for Clinical Parasitology (ESGCP)

Convenor: Eskild Petersen (Aarhus, DK)

• Chagas’ disease
  Joaquim Gascón (Barcelona, ES)
• Trichinellosis
  Eduardo Pozio (Rome, IT)
• Fasciolosis and opistorchiasis
  Eskild Petersen (Aarhus, DK)
• Multilocular echinococcosis
  Peter Deplazes (Zurich, CH)

EW11: Definitions and treatment outcome criteria in invasive fungal infections: an interactive workshop to reach a broader consensus

Arranged with the European Organisation for Research and Treatment of Cancer (EORTC) and the Immunocompromised Host Society (ICHS)

Convenors: Claudio Viscoli (Genoa, IT); Johan Maertens (Leuven, BE)

• Definitions of invasive fungal infections
  Peter Donnelly (Nijmegen, NL)
• Treatment outcome definitions in aspergillosis
  Raoul Herbrecht (Strasbourg, FR)
• Treatment outcome definitions in invasive candidiasis and candidaemia
  Brahm Segal (Buffalo, US)

EW12: Carbapenem resistance in non-fermenters

Arranged with the ESCMID Study Group for Antimicrobial Resistance Surveillance (ESGARS)

Convenors: Luis Martinez-Martinez (Santander, ES); Gian Maria Rossolini (Siena, IT), represented by Giuseppe Cornaglia (Verona, IT)

• The role of beta-lactamases
  Gian Maria Rossolini (Siena, IT), represented by Alkis Vatopoulos (Athens, GR)
• The role of efflux/influx mechanisms
  Luis Martinez-Martinez (Santander, ES)
• How to detect and characterize the resistant isolates
  Dora Szabó (Budapest, HU)
• Alert systems, surveillance networks and molecular epidemiology
  Alkis Vatopoulos (Athens, GR)

EW13: Scientific writing: how to go about it

Arranged by ESCMID

Convenors: Judith Crane (Paris, FR); Panayotis Tassios (Athens, GR)

• What an editor wants to see in a submission
  Sherwood Gorbach (Boston, US)
• Logical presentation: how to present your data in the best light
  George Schmid (Geneva, CH)
• How to make a favourable impression on reviewers
  Trish Groves (London, UK)
• English usage: simple language for complicated matters
  Panayotis Tassios (Athens, GR)

EW14: Pathogenic intracellular bacteria

Arranged with the ESCMID Study Group for Coxiella, Anaplasma, Rickettsia and Bartonella (ESCAR)

Convenors: Gilbert Greub (Lausanne, CH); Pierre-Edouard Fournier (Marseille, FR)

• Spotted fever rickettsiosis
  Amel Omezzine Letaief (Sousse, TN)
• Bartonella: from cat-scratch disease to endocarditis
  Pierre-Edouard Fournier (Marseille, FR)
• Chronic Q fever: from diagnosis to treatment
  Achilleas Gikas (Heraklion, GR)
• Role of emerging intracellular bacteria in pneumonia
  Gilbert Greub (Lausanne, CH)